People News: Celgene and Avantium
Avantium appointed Gunnar Staaf CEO of its pharmaceutical business. Staaf previously worked at Serentis, Astellas Pharma, Novartis and Eli Lilly.
The regimen's anticipated average price of $80,000 is expected to determine how competitors stay competitive.
Haymarket Media Group launched an American version of the publisher's Campaign UK media brand this week.
Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.